The scarring of lungs is caused by some unknown origin. The exact mechanism of action of Pirfenidone (Pirfetab 200mg) is not known. Pirfenidone (Pirfetab 200mg) is thought to reduce the lung ...

Pirfenidone is currently approved for treating adults with idiopathic lung fibrosis, or scarring in the lungs that makes it hard to breathe. While the mechanism of action has not been fully ...

Nerandomilast is a preferential inhibitor of phosphodiesterase 4B (PDE4B) with antifibrotic and immunomodulatory effects, a mechanism different than approved antifibrotic treatments pirfenidone ...

and pirfenidone (Esbriet), both of which can slow disease progression. Nerandomilast, which inhibits the enzyme phosphodiesterase 4B (PDE4B), is poised to offer a novel mechanism of action that ...

The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising ...